vs

Side-by-side financial comparison of Indonesia Energy Corp Ltd (INDO) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.4M, roughly 1.4× Indonesia Energy Corp Ltd). Indonesia Energy Corp Ltd runs the higher net margin — -195.5% vs -13301.2%, a 13105.7% gap on every dollar of revenue. On growth, Indonesia Energy Corp Ltd posted the faster year-over-year revenue change (0.0% vs -77.8%).

PT Kino Indonesia Tbk, formerly PT Kinocare Era Kosmetindo, or simply known as Kino, is an Indonesian multinational consumer goods company headquartered in Tangerang, Banten, founded in 1999 by Harry Sanusi. It specializes the manufacturing of its products in the wide range of personal care, hygiene, health care, confectionery, pastry, beverages, and pet care. As of 2022, the company is currently led by Sidharta Prawira Oetama as its president director while Sanusi act as its president commis...

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

INDO vs ROIV — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.4× larger
ROIV
$2.0M
$1.4M
INDO
Growing faster (revenue YoY)
INDO
INDO
+77.8% gap
INDO
0.0%
-77.8%
ROIV
Higher net margin
INDO
INDO
13105.7% more per $
INDO
-195.5%
-13301.2%
ROIV

Income Statement — Q2 FY2025 vs Q3 FY2026

Metric
INDO
INDO
ROIV
ROIV
Revenue
$1.4M
$2.0M
Net Profit
$-2.8M
$-265.9M
Gross Margin
Operating Margin
-167.8%
-16966.1%
Net Margin
-195.5%
-13301.2%
Revenue YoY
0.0%
-77.8%
Net Profit YoY
-34.5%
-257.0%
EPS (diluted)
$-0.19
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDO
INDO
ROIV
ROIV
Q4 25
$2.0M
Q3 25
$1.6M
Q2 25
$1.4M
$2.2M
Q1 25
$-39.6M
Q4 24
$9.0M
Q3 24
$4.5M
Q2 24
$1.8M
$8.0M
Q1 24
$28.9M
Net Profit
INDO
INDO
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$-113.5M
Q2 25
$-2.8M
$-223.4M
Q1 25
$-206.5M
Q4 24
$169.4M
Q3 24
$-230.2M
Q2 24
$-2.1M
$95.3M
Q1 24
$-151.1M
Operating Margin
INDO
INDO
ROIV
ROIV
Q4 25
-16966.1%
Q3 25
-19492.9%
Q2 25
-167.8%
-13130.0%
Q1 25
674.8%
Q4 24
-3042.6%
Q3 24
-7636.0%
Q2 24
-102.7%
-1279.5%
Q1 24
-919.5%
Net Margin
INDO
INDO
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
-7225.9%
Q2 25
-195.5%
-10292.9%
Q1 25
521.8%
Q4 24
1878.3%
Q3 24
-5143.8%
Q2 24
-114.0%
1192.7%
Q1 24
-522.3%
EPS (diluted)
INDO
INDO
ROIV
ROIV
Q4 25
$-0.38
Q3 25
$-0.17
Q2 25
$-0.19
$-0.33
Q1 25
$-0.28
Q4 24
$0.23
Q3 24
$-0.31
Q2 24
$-0.26
$0.12
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDO
INDO
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$21.9M
$4.3B
Total Assets
$25.2M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDO
INDO
ROIV
ROIV
Q4 25
$4.5B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.9B
Q4 24
$5.1B
Q3 24
$5.4B
Q2 24
$5.7B
Q1 24
$6.5B
Total Debt
INDO
INDO
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
INDO
INDO
ROIV
ROIV
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$21.9M
$4.3B
Q1 25
$4.7B
Q4 24
$5.2B
Q3 24
$5.2B
Q2 24
$13.1M
$5.4B
Q1 24
$6.0B
Total Assets
INDO
INDO
ROIV
ROIV
Q4 25
$5.2B
Q3 25
$5.1B
Q2 25
$25.2M
$5.0B
Q1 25
$5.4B
Q4 24
$5.8B
Q3 24
$6.2B
Q2 24
$17.5M
$6.5B
Q1 24
$7.2B
Debt / Equity
INDO
INDO
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDO
INDO
ROIV
ROIV
Operating Cash FlowLast quarter
$-2.5M
$-196.5M
Free Cash FlowOCF − Capex
$-201.4M
FCF MarginFCF / Revenue
-10076.0%
Capex IntensityCapex / Revenue
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDO
INDO
ROIV
ROIV
Q4 25
$-196.5M
Q3 25
$-185.7M
Q2 25
$-2.5M
$-204.4M
Q1 25
$-172.6M
Q4 24
$-207.3M
Q3 24
$-266.8M
Q2 24
$-700.9K
$-192.8M
Q1 24
$-108.5M
Free Cash Flow
INDO
INDO
ROIV
ROIV
Q4 25
$-201.4M
Q3 25
$-193.5M
Q2 25
$-208.4M
Q1 25
$-173.4M
Q4 24
$-209.1M
Q3 24
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
INDO
INDO
ROIV
ROIV
Q4 25
-10076.0%
Q3 25
-12317.8%
Q2 25
-9604.5%
Q1 25
438.1%
Q4 24
-2318.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
INDO
INDO
ROIV
ROIV
Q4 25
246.9%
Q3 25
499.6%
Q2 25
185.9%
Q1 25
-2.0%
Q4 24
20.3%
Q3 24
22.3%
Q2 24
12.1%
Q1 24
1.2%
Cash Conversion
INDO
INDO
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons